Compositions and methods for treating obesity and hyperphagia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11400135
APP PUB NO 20200155649A1
SERIAL NO

16781304

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure is directed to the treatment of diseases or conditions characterized by the buildup of fatty tissue, or hyperphagia, such as Prader-Willi syndrome, obesity, metabolic syndrome, type II diabetes, etc. A composition containing a monoclonal antibody directed against gastric inhibitory polypeptide is administered. This results in a reduced rate of weight gain, weight loss, and/or reduction in fatty tissue, and a marked decrease in lipid synthesis and accumulation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • MHS CARE-INNOVATION LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boylan, Michael O Milton, US 8 26
Wolfe, M Michael Bal Harbour, US 23 142

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 2, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 2, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 2, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00